Catheter Connections Secures Three Additional U.S. Patents

Share Article

DualCap System™ Core Technology Protected by 17 Patents

News Image
As the leading innovator in this field, the CCI team is dedicated to helping healthcare professionals improve patient safety by preventing CRBSIs.

Catheter Connections, Inc. (CCI) today announced the issuance of three additional patents from the United States Patent and Trademark Office covering its proprietary DualCap System TM. DualCap® helps prevent catheter-related bloodstream infections (CRBSIs), including central line-associated blood stream infections (CLABSIs), to improve patient safety during intravenous (IV) therapy.

The three newly issued patents add to the core patented technology that comprises the company’s DualCap System platform. Two of the patents cover the disinfection cap technology designed to protect the male luer connector at the end of IV tubing. The third patent covers the IV Pole Strips™ that provide convenient bedside delivery of the dark blue cap for the male luer connectors on the IV tubing end, and the light blue cap for needle-free valves.

“As the leading innovator in this field, the CCI team is dedicated to helping healthcare professionals improve patient safety by preventing CRBSIs,” said Catheter Connections CEO John P. Shannon. “Our product enhancements will always be designed to respond to the needs of nurses and other healthcare professionals.”

CCI continues to add future technological advancements to its current patent estate, which includes 17 patents in the U.S. and several outside of the U.S., that confers broad and comprehensive intellectual property coverage on the DualCap System.

About Catheter Connections

Headquartered in Salt Lake City, Utah, Catheter Connections, Inc. (CCI) develops and commercializes innovative vascular access products designed to help protect patients from acquiring infections during intravenous (IV) infusion therapy. Its proprietary DualCap System TM provides rapid and ongoing protection against bacterial contamination. Designed by nurses for nurses, the family of easy-to-use products provides healthcare facilities with a cost-effective, integrated solution for helping in the fight against IV catheter-related blood stream infections (CRBSIs), including central line-associated blood stream infections (CLABSIs).

For more information, visit http://www.catheterconnections.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jed Weiner
White Oak Communications, Inc.
+1 (847) 910-1330
Email >